Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC64415;416;417 chr2:178802243;178802242;178802241chr2:179666970;179666969;179666968
N2AB64415;416;417 chr2:178802243;178802242;178802241chr2:179666970;179666969;179666968
N2A64415;416;417 chr2:178802243;178802242;178802241chr2:179666970;179666969;179666968
N2B64415;416;417 chr2:178802243;178802242;178802241chr2:179666970;179666969;179666968
Novex-164415;416;417 chr2:178802243;178802242;178802241chr2:179666970;179666969;179666968
Novex-264415;416;417 chr2:178802243;178802242;178802241chr2:179666970;179666969;179666968
Novex-364415;416;417 chr2:178802243;178802242;178802241chr2:179666970;179666969;179666968

Information

  • RefSeq wild type amino acid: K
  • RefSeq wild type transcript codon: AAA
  • RefSeq wild type template codon: TTT
  • Domain: Ig-1
  • Domain position: 59
  • Structural Position: 137
  • Q(SASA): 0.2051
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
K/I None None 0.001 N 0.515 0.232 0.20549828249 gnomAD-4.0.0 1.59049E-06 None None None -0.354(TCAP) N None 0 0 None 0 0 None 0 0 0 0 3.02151E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
K/A 0.3274 likely_benign 0.3768 ambiguous -1.102 Destabilizing 0.037 N 0.397 neutral None None None -0.249(TCAP) N
K/C 0.6605 likely_pathogenic 0.7107 pathogenic -1.276 Destabilizing 0.946 D 0.609 neutral None None None -0.145(TCAP) N
K/D 0.7739 likely_pathogenic 0.8039 pathogenic -1.067 Destabilizing 0.177 N 0.493 neutral None None None 0.1(TCAP) N
K/E 0.236 likely_benign 0.2572 benign -0.875 Destabilizing 0.01 N 0.429 neutral N 0.469217228 None 0.018(TCAP) N
K/F 0.6643 likely_pathogenic 0.7248 pathogenic -0.629 Destabilizing 0.378 N 0.603 neutral None None None -0.034(TCAP) N
K/G 0.4767 ambiguous 0.5334 ambiguous -1.533 Destabilizing 0.177 N 0.564 neutral None None None -0.223(TCAP) N
K/H 0.2477 likely_benign 0.2873 benign -1.805 Destabilizing 0.388 N 0.578 neutral None None None 0.249(TCAP) N
K/I 0.2331 likely_benign 0.2503 benign 0.064 Stabilizing 0.001 N 0.515 neutral N 0.489424891 None -0.354(TCAP) N
K/L 0.2742 likely_benign 0.3075 benign 0.064 Stabilizing 0.001 N 0.481 neutral None None None -0.354(TCAP) N
K/M 0.1864 likely_benign 0.2059 benign -0.099 Destabilizing 0.154 N 0.573 neutral None None None 0.171(TCAP) N
K/N 0.5065 ambiguous 0.5514 ambiguous -1.216 Destabilizing 0.14 N 0.391 neutral N 0.491486757 None -0.522(TCAP) N
K/P 0.976 likely_pathogenic 0.9791 pathogenic -0.298 Destabilizing 0.304 N 0.547 neutral None None None -0.315(TCAP) N
K/Q 0.1044 likely_benign 0.1198 benign -1.166 Destabilizing 0.01 N 0.449 neutral N 0.489136921 None -0.375(TCAP) N
K/R 0.0656 likely_benign 0.0704 benign -0.926 Destabilizing None N 0.193 neutral N 0.452408785 None -0.875(TCAP) N
K/S 0.3789 ambiguous 0.4423 ambiguous -1.864 Destabilizing 0.043 N 0.395 neutral None None None -0.4(TCAP) N
K/T 0.1291 likely_benign 0.1504 benign -1.435 Destabilizing None N 0.292 neutral N 0.358649071 None -0.444(TCAP) N
K/V 0.2216 likely_benign 0.2465 benign -0.298 Destabilizing None N 0.449 neutral None None None -0.315(TCAP) N
K/W 0.601 likely_pathogenic 0.6914 pathogenic -0.545 Destabilizing 0.963 D 0.642 neutral None None None 0.077(TCAP) N
K/Y 0.5649 likely_pathogenic 0.6133 pathogenic -0.205 Destabilizing 0.067 N 0.613 neutral None None None 0.077(TCAP) N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.